165 related articles for article (PubMed ID: 22301782)
1. CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.
Dorman K; Shen Z; Yang C; Ezzat S; Asa SL
Mol Endocrinol; 2012 Mar; 26(3):447-57. PubMed ID: 22301782
[TBL] [Abstract][Full Text] [Related]
2. Ikaros and its interacting partner CtBP target the metalloprotease ADAMTS10 to modulate pituitary cell function.
Shen Z; Asa SL; Ezzat S
Mol Cell Endocrinol; 2017 Jan; 439():126-132. PubMed ID: 27815209
[TBL] [Abstract][Full Text] [Related]
3. The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitary.
Shen Z; Asa SL; Ezzat S
Mol Cell Endocrinol; 2018 Feb; 461():188-193. PubMed ID: 28919299
[TBL] [Abstract][Full Text] [Related]
4. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.
Ezzat S; Yu S; Asa SL
Am J Pathol; 2003 Sep; 163(3):1177-84. PubMed ID: 12937159
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells.
Ezzat S; Zhu X; Loeper S; Fischer S; Asa SL
Mol Endocrinol; 2006 Nov; 20(11):2976-86. PubMed ID: 16873443
[TBL] [Abstract][Full Text] [Related]
6. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
[TBL] [Abstract][Full Text] [Related]
7. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.
Kuppuswamy M; Vijayalingam S; Zhao LJ; Zhou Y; Subramanian T; Ryerse J; Chinnadurai G
Mol Cell Biol; 2008 Jan; 28(1):269-81. PubMed ID: 17967884
[TBL] [Abstract][Full Text] [Related]
8. AIP gene and familial isolated pituitary adenomas.
Ozfirat Z; Korbonits M
Mol Cell Endocrinol; 2010 Sep; 326(1-2):71-9. PubMed ID: 20457215
[TBL] [Abstract][Full Text] [Related]
9. Role of transcriptional corepressor CtBP1 in prostate cancer progression.
Wang R; Asangani IA; Chakravarthi BV; Ateeq B; Lonigro RJ; Cao Q; Mani RS; Camacho DF; McGregor N; Schumann TE; Jing X; Menawat R; Tomlins SA; Zheng H; Otte AP; Mehra R; Siddiqui J; Dhanasekaran SM; Nyati MK; Pienta KJ; Palanisamy N; Kunju LP; Rubin MA; Chinnaiyan AM; Varambally S
Neoplasia; 2012 Oct; 14(10):905-14. PubMed ID: 23097625
[TBL] [Abstract][Full Text] [Related]
10. A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity.
Beck DB; Subramanian T; Vijayalingam S; Ezekiel UR; Donkervoort S; Yang ML; Dubbs HA; Ortiz-Gonzalez XR; Lakhani S; Segal D; Au M; Graham JM; Verma S; Waggoner D; Shinawi M; Bönnemann CG; Chung WK; Chinnadurai G
Neurogenetics; 2019 Aug; 20(3):129-143. PubMed ID: 31041561
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract][Full Text] [Related]
12. The CtBP1-p300-FOXO3a transcriptional complex represses the expression of the apoptotic regulators Bax and Bim in human osteosarcoma cells.
Li C; Xiao XQ; Qian YH; Zhou ZY
J Cell Physiol; 2019 Dec; 234(12):22365-22377. PubMed ID: 31074088
[TBL] [Abstract][Full Text] [Related]
13. C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells.
Deng Y; Li H; Yin X; Liu H; Liu J; Guo D; Shi Z
Med Sci Monit; 2018 Oct; 24():7614-7624. PubMed ID: 30356033
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
Li M; Riddle S; Zhang H; D'Alessandro A; Flockton A; Serkova NJ; Hansen KC; Moldovan R; McKeon BA; Frid M; Kumar S; Li H; Liu H; Caánovas A; Medrano JF; Thomas MG; Iloska D; Plecitá-Hlavatá L; Ježek P; Pullamsetti S; Fini MA; El Kasmi KC; Zhang Q; Stenmark KR
Circulation; 2016 Oct; 134(15):1105-1121. PubMed ID: 27562971
[TBL] [Abstract][Full Text] [Related]
15. CtBP determines ovarian cancer cell fate through repression of death receptors.
Ding B; Yuan F; Damle PK; Litovchick L; Drapkin R; Grossman SR
Cell Death Dis; 2020 Apr; 11(4):286. PubMed ID: 32332713
[TBL] [Abstract][Full Text] [Related]
16. Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells.
Zhang Y; Kwok JS; Choi PW; Liu M; Yang J; Singh M; Ng SK; Welch WR; Muto MG; Tsui SK; Sugrue SP; Berkowitz RS; Ng SW
Oncotarget; 2016 Mar; 7(10):11397-411. PubMed ID: 26871283
[TBL] [Abstract][Full Text] [Related]
17. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
Wang J; Zhang Z; Li R; Sun W; Chen J; Zhang H; Shu K; Lei T
Life Sci; 2018 Feb; 194():150-156. PubMed ID: 29288766
[TBL] [Abstract][Full Text] [Related]
19. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
20. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity.
Koipally J; Georgopoulos K
J Biol Chem; 2000 Jun; 275(26):19594-602. PubMed ID: 10766745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]